Xenobiotic Metabolism and Disposition: The Design of Studies on Novel Compounds

Copertina anteriore
CRC Press, 28 feb 1989 - 232 pagine
This publication explains the principles of the techniques used in disposition and metabolism studies in animals, in man, and in vitro. It includes methods for studying routes and rates of absorption, distribution, metabolism, and excretion of novel compounds and their metabolites. Relevant surgical, whole-body autoradiographic and pharmacokinetic procedures are discussed, together with techniques for separating and identifying metabolites and metabolic path-ways. Information on when the procedures are appropriate, and examples of what they represent, are presented in order to illustrate the value of such stud-ies.

Dall'interno del libro

Sommario

Introduction
4
Chapter 2
19
Chapter
23
14
36
Chapter 4
41
Chapter 5
67
Chapter 6
83
Chapter 8
99
Chapter 9
149
Chapter 10
171
Biochemical Studies on Induction Inhibition and Activation
193
Index
215
Copyright

Altre edizioni - Visualizza tutto

Parole e frasi comuni

Brani popolari

Pagina 220 - Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants, Cancer Res., 38 (1978) 4486.
Pagina 220 - Separation and characterization of highly purified forms of liver microsomal cytochrome P-450 from rats treated with polychlorinated biphenyls, phenobarbital, and 3-methylcholanthrene, J.

Riferimenti a questo libro

Drug Toxicokinetics
Welling
Anteprima non disponibile - 1993

Informazioni sull'autore (1989)

H. Paul A. Illing, Ph.D., F.I.Biol., F.R.S.C., Dip.R.C. Path., is Head of Toxicology in the Medical Division of the Health and Safety Executive, Merseyside, U.K., Dr. Illing studied at Queens College, Dundee (from 1967, University of Dundee) and graduated B.Sc. (St. Andrews) in 1969 and Ph.D. (Dundee) in 1972. Following a period at the University of Mainz (West Germany) as aWellcome Trust/DFG Fellow, Dr. Illing was a Scientist and Senior Scientist in Drug Metabolism and Pharmacokinetics at Hoechst Pharmaceutical Research Laboratories, Milton Keynes, U.K. from 1974 to 1982. Since 1982 he has been at the Health and Safety Executive where he was appointed to his present position in 1986., Dr. Illing is a Fellow of the Institute of Biology and of the Royal Society of Chemistry and holds the Diploma in Toxicology of the Royal College of Pathologists. He is a member of the Biochemical Society, the British Toxicology Society, and the U.K. Environmental Mutagenicity Society., Dr. Illing's interests include methods for studying foreign compound metabolism and the role of such studies in understanding the biological effects of chemicals.

Informazioni bibliografiche